Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
MyImmune Logo
MyImmune Growth Score
75
CB Rank
268039
Heat Score
79
MyImmune builds AI software for immune profiling, patient stratification, and natural antibody discovery platform
Founded
obfuscation
PrivateNon-equity Assistance Wilmington, Delaware, United States1-10 myimmune.ai
Artificial Intelligence (AI)
Biotechnology
Health Diagnostics
Software
Overview

MyImmune
Growth Score
75
Heat Score
79

Growth Score75
41 pts
in past quarter
Heat Score 79
-10 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About MyImmune

CB Rank
268039
MyImmune builds AI software for immune profiling, patient stratification, and natural antibody discovery platform
Founded
obfuscation
PrivateNon-equity Assistance Wilmington, Delaware, United States1-10 myimmune.ai
Artificial Intelligence (AI)
Biotechnology
Health Diagnostics
Software

Funding Rounds

Non-equity Assistance
OBF
in
obfuscation
Pre-Seed
OBF
in
obfuscation

Key People

  • Photo of Daron Standley
    Daron Standley: Chief Scientific Advisor and Co-Founder
    Past Role: KOTAI Biotechnologies, Co-Founder
  • Photo of Ayan Sengupta
    Ayan Sengupta: CEO, Myimmune
    Past Role: MyImmune, CTO & Co-Founder

Details

Legal Name MyImmune Corporation
Operating Status Active
Company Type For Profit
Founders  Ayan Sengupta, Daron Standley, Florian Hauer
About the Company
ImmuneOS: MyImmune develops AI software that models immune status from clinical, laboratory, and molecular data. The platform computes immune signatures, flags anomalies, and helps interpret longitudinal changes. AbSapien: Natural antibody discovery platform
Contact Email admin@myimmune.ai
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Runway Speculation

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Non Equity Assistance - MyImmune Logo
Non Equity Assistance - MyImmune
1
obfuscation
Flagship Traction ProgramNon-equity Assistance
obfuscation
Non Equity Assistance - MyImmune Logo
Non Equity Assistance - MyImmune
1
obfuscation
Flagship Traction ProgramNon-equity Assistance
obfuscation
Non Equity Assistance - MyImmune Logo
Non Equity Assistance - MyImmune
1
obfuscation
Flagship Traction ProgramNon-equity Assistance
obfuscation
Non Equity Assistance - MyImmune Logo
Non Equity Assistance - MyImmune
1
obfuscation
Flagship Traction ProgramNon-equity Assistance
obfuscation
Non Equity Assistance - MyImmune Logo
Non Equity Assistance - MyImmune
1
obfuscation
Flagship Traction ProgramNon-equity Assistance

Funding Rounds

Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Non Equity Assistance - MyImmune Logo
Non Equity Assistance - MyImmune
1
obfuscation
Flagship Traction ProgramNon-equity Assistance
obfuscation
Non Equity Assistance - MyImmune Logo
Non Equity Assistance - MyImmune
1
obfuscation
Flagship Traction ProgramNon-equity Assistance
obfuscation
Non Equity Assistance - MyImmune Logo
Non Equity Assistance - MyImmune
1
obfuscation
Flagship Traction ProgramNon-equity Assistance
obfuscation
Non Equity Assistance - MyImmune Logo
Non Equity Assistance - MyImmune
1
obfuscation
Flagship Traction ProgramNon-equity Assistance
obfuscation
Non Equity Assistance - MyImmune Logo
Non Equity Assistance - MyImmune
1
obfuscation
Flagship Traction ProgramNon-equity Assistance

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 2 Board Members and Advisors 1

Employee Profiles

Board Members and Advisors

News
Technology
View Tech Report

Active Website Tech Count

7MyImmune is actively using 7 technologies for its website, according to BuiltWith. These include Viewport Meta, IPhone / Mobile Compatible, and  Cloudflare.
Sub-Organizations
Frequently Asked Questions

Where is MyImmune's headquarters? MyImmune is located in Wilmington, Delaware, United States.Who invested in MyImmune? MyImmune has 2 investors including Flagship Traction Program and  Osaka University Venture Capital.When was the last funding round for MyImmune? MyImmune closed its last funding round on
obfuscation
from a Non-equity Assistance round.Who are MyImmune's competitors? Alternatives and possible competitors to MyImmune may include Tempus, SOPHiA GENETICS, and  Immunai.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(5d42803 1)
|